Dr. David Carron, MD

NPI: 1023085487
Total Payments
$497.31
2023 Payments
$25.32
Companies
3
Transactions
15
Medicare Patients
2,475
Medicare Billing
$271,803

Payment Breakdown by Category

Food & Beverage$497.31 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $497.31 15 100.0%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $261.52 7 $0 (2022)
Daiichi Sankyo Inc. $125.43 6 $0 (2023)
BOSTON SCIENTIFIC CORPORATION $110.36 2 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2023 $25.32 1 Daiichi Sankyo Inc. ($25.32)
2022 $49.85 2 ABBVIE INC. ($49.85)
2021 $55.25 2 AbbVie Inc. ($55.25)
2019 $74.05 1 AbbVie, Inc. ($74.05)
2018 $200.92 8 Daiichi Sankyo Inc. ($100.11)
2017 $91.92 1 BOSTON SCIENTIFIC CORPORATION ($91.92)

All Payment Transactions

15 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
03/23/2023 Daiichi Sankyo Inc. INJECTAFER (Drug) Food and Beverage In-kind items and services $25.32 General
Category: Iron Deficiency Anemia
04/13/2022 ABBVIE INC. LINZESS (Drug) Food and Beverage In-kind items and services $29.08 General
Category: GASTROENTEROLOGY
03/10/2022 ABBVIE INC. LINZESS (Drug) Food and Beverage In-kind items and services $20.77 General
Category: GASTROENTEROLOGY
11/03/2021 AbbVie Inc. Food and Beverage In-kind items and services $39.82 General
11/02/2021 AbbVie Inc. LINZESS (Drug), CREON Food and Beverage In-kind items and services $15.43 General
Category: GASTROENTEROLOGY
11/02/2019 AbbVie, Inc. Food and Beverage In-kind items and services $74.05 General
11/06/2018 AbbVie, Inc. Humira (Biological) Food and Beverage In-kind items and services $58.80 General
Category: Immunology
10/29/2018 BOSTON SCIENTIFIC CORPORATION GENERAL BIOPSY (Device) Food and Beverage In-kind items and services $18.44 General
Category: BIOPSY
08/27/2018 Daiichi Sankyo Inc. Movantik (Drug) Food and Beverage In-kind items and services $23.03 General
Category: Opioid Induced Constipation
08/23/2018 Daiichi Sankyo Inc. Morphabond ER (Drug) Food and Beverage In-kind items and services $16.29 General
Category: Pain Management
07/11/2018 AbbVie, Inc. Food and Beverage In-kind items and services $23.57 General
05/11/2018 Daiichi Sankyo Inc. Morphabond ER (Drug) Food and Beverage In-kind items and services $21.61 General
Category: Pain Management
03/06/2018 Daiichi Sankyo Inc. INJECTAFER (Drug) Food and Beverage In-kind items and services $22.59 General
Category: Anemia
01/22/2018 Daiichi Sankyo Inc. INJECTAFER (Drug) Food and Beverage In-kind items and services $16.59 General
Category: Anemia
11/03/2017 BOSTON SCIENTIFIC CORPORATION GENERAL - THERAPIES (Device) Food and Beverage In-kind items and services $91.92 General
Category: THERAPIES

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 12 509 530 $987,966 $56,607
2022 16 645 698 $1.2M $69,211
2021 15 684 739 $1.1M $77,175
2020 15 637 689 $1.1M $68,809
Total Patients
2,475
Total Services
2,656
Medicare Billing
$271,803
Procedure Codes
58

All Medicare Procedures & Services

58 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2023 130 130 $390,750 $22,980 5.9%
G0105 Colorectal cancer screening; colonoscopy on individual at high risk Facility 2023 46 46 $118,390 $7,321 6.2%
45380 Biopsy of large bowel using a flexible endoscope Facility 2023 61 62 $174,681 $6,004 3.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 43 49 $12,642 $3,913 30.9%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 61 68 $14,416 $3,791 26.3%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2023 74 75 $154,575 $3,681 2.4%
G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk Facility 2023 17 17 $43,639 $2,707 6.2%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 20 20 $9,960 $1,849 18.6%
43249 Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm Facility 2023 17 17 $35,037 $1,276 3.6%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 14 14 $6,608 $1,105 16.7%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 12 18 $4,392 $1,001 22.8%
43235 Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2023 14 14 $22,876 $979.43 4.3%
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2022 126 126 $367,416 $21,964 6.0%
G0105 Colorectal cancer screening; colonoscopy on individual at high risk Facility 2022 62 62 $154,504 $10,000 6.5%
45380 Biopsy of large bowel using a flexible endoscope Facility 2022 74 74 $202,020 $7,619 3.8%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2022 95 98 $196,098 $5,524 2.8%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 63 71 $14,555 $3,904 26.8%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 36 73 $17,228 $3,708 21.5%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 26 26 $14,690 $3,675 25.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 39 44 $11,000 $3,635 33.0%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 19 19 $9,177 $1,940 21.1%
G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk Facility 2022 12 12 $29,904 $1,873 6.3%
43249 Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm Facility 2022 14 14 $28,014 $1,354 4.8%
43248 Insertion of guide wire with dilation of esophagus using a flexible endoscope Facility 2022 12 12 $24,012 $1,301 5.4%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 18 18 $7,038 $1,202 17.1%

About Dr. David Carron, MD

Dr. David Carron, MD is a Gastroenterology healthcare provider based in Milwaukee, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1023085487.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Carron, MD has received a total of $497.31 in payments from pharmaceutical and medical device companies, with $25.32 received in 2023. These payments were reported across 15 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($497.31).

As a Medicare-enrolled provider, Carron has provided services to 2,475 Medicare beneficiaries, totaling 2,656 services with total Medicare billing of $271,803. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.

Practice Information

  • Specialty Gastroenterology
  • Location Milwaukee, WI
  • Active Since 03/03/2006
  • Last Updated 01/26/2026
  • Taxonomy Code 207RG0100X
  • Entity Type Individual
  • NPI Number 1023085487

Products in Payments

  • GENERAL - THERAPIES (Device) $91.92
  • LINZESS (Drug) $65.28
  • INJECTAFER (Drug) $64.50
  • Humira (Biological) $58.80
  • Morphabond ER (Drug) $37.90
  • Movantik (Drug) $23.03
  • GENERAL BIOPSY (Device) $18.44

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Gastroenterology Doctors in Milwaukee